These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 12699795

  • 1. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
    Hawe J, Abbott J, Hunter D, Phillips G, Garry R.
    BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA, Farquhar CM, Sowter MC, Lethaby A, Sprecher M, Yu Y, Sadler LC, Brown P, Johnson N.
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [Abstract] [Full Text] [Related]

  • 5. Bipolar radio frequency endometrial ablation compared with balloon endometrial ablation in dysfunctional uterine bleeding: impact on patients' health-related quality of life.
    Bongers MY, Bourdrez P, Heintz AP, Brölmann HA, Mol BW.
    Fertil Steril; 2005 Mar; 83(3):724-34. PubMed ID: 15749505
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endometrial ablation for von Willebrand disease-related menorrhagia--experience with seven cases.
    Rubin G, Wortman M, Kouides PA.
    Haemophilia; 2004 Sep; 10(5):477-82. PubMed ID: 15357774
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation.
    Kleijn JH, Engels R, Bourdrez P, Mol BW, Bongers MY.
    BJOG; 2008 Jan; 115(2):193-8. PubMed ID: 17617188
    [Abstract] [Full Text] [Related]

  • 10. Global endometrial ablation for menorrhagia in women with bleeding disorders.
    El-Nashar SA, Hopkins MR, Feitoza SS, Pruthi RK, Barnes SA, Gebhart JB, Cliby WA, Famuyide AO.
    Obstet Gynecol; 2007 Jun; 109(6):1381-7. PubMed ID: 17540811
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ten-year follow-up of endometrial ablation.
    Fürst SN, Philipsen T, Joergensen JC.
    Acta Obstet Gynecol Scand; 2007 Jun; 86(3):334-8. PubMed ID: 17364309
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Current treatment of dysfunctional uterine bleeding.
    Bongers MY, Mol BW, Brölmann HA.
    Maturitas; 2004 Mar 15; 47(3):159-74. PubMed ID: 15036486
    [Abstract] [Full Text] [Related]

  • 17. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding.
    Abbott J, Hawe J, Hunter D, Garry R.
    Fertil Steril; 2003 Jul 15; 80(1):203-8. PubMed ID: 12849825
    [Abstract] [Full Text] [Related]

  • 18. Factors affecting the outcome of endometrial ablation using Cavaterm plus.
    Julian S, Habiba M.
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov 01; 123(1):92-7. PubMed ID: 15893872
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.